Buradasınız

Anasayfa » Content

Erken doğumun önlenmesinde nifedipin ve ritodrinin karşılaştırılması

A comparison of nifedipine and ritodrine in the management of preterm labor

Journal Name:

  • Gülhane Tıp Dergisi

Publication Year:

  • 2007

Key Words:

Keywords (Original Language):

Author Name
Abstract (2. Language): 
We compared the efficacy of nifedipine and ritodrine in the treatment of preterm labor. A total of 135 cases diagnosed to have preterm labor were retrospectively evaluated. Of all the cases 73 and 62 were given nifedipine and ritodrine, respectively. The main outcome measure was the period of delay in delivery. The number of delivered patients within 48 hours were 14 (19.2%) and 23 (37.1%) in patients receiving nifedipine and ritodrine, respectively (p=0.032). Twenty one cases (28.8%) in the nifedipine group and 30 cases (48.4%) in the ritodrine group delivered within 1 week (p=0.022). Thirty cases (41.1%) in the nifedipine group and 37 cases (59.7%) in the ritodrine group delivered before 35 weeks of gestation (p=0.039). There were significantly lower maternal side effects in the nifedipine group than in the ritodrine group. The number of newborns transferred to the neonatal intensive care unit was significantly lower in the nifedipine group when compared to the ritodrine group (p<0.05). Nifedipin treatment, when compared to ritodrine, is more effective in delaying labor in the management of preterm labor. On the basis of the results of the present study we conclude that use of nifedipine is more effective in the treatment of preterm labor when compared to ritodrine treatment.
Bookmark/Search this post with
Abstract (Original Language): 
Çalışmamızda erken doğumun önlenmesinde nifedipin ve ritodrin tedavilerinin etkinliği karşılaştırıldı. Erken eylem tanısı alan toplam 135 olgu retrospektif olarak incelendi. Bu olgulardan, 73'üne nifedipin ve 62'sine ritodrin tedavisi uygulanmıştı. Sonuçlar doğum eyleminin geciktirilmesi olarak değerlendirildi. Nifedipin tedavisi alan grupta 48 saat içinde doğum yapanların sayısı 14 iken (%19.2), ritodrin alan grupta ise 23 (%37.1) olarak saptandı (p=0.032). Bir hafta içerisinde doğum yapanların sayısı nifedipin alan grupta 21 iken (%28.8), ritodrin alan grupta ise 30 (%48.4) olarak bulundu (p=0.022). Otuz beş haftadan önce doğum yapanların sayısı nifedipin alan grupta 30 (%41.1), ritodrin alan grupta ise 37 (%59.7) olarak saptandı (p=0.039). Nifedipin alan grupta yan etki sıklığı anlamlı şekilde daha az bulundu. Yenidoğan yoğun bakım ünitesine nakledilen yenidoğanların sayısı, nifedipin alan grupta ritodrin alan gruba göre daha az idi (p<0.05). Nifedipin tedavisi ritodrin tedavisi ile karşılaştırıldığında preterm eylemde doğumu geciktirme açısından daha etkili olarak bulundu. Bu çalışmanın sonuçlarına göre erken doğum tedavisinde nifedipin kullanımının ritodrin tedavisine göre daha etkili olduğu sonucuna varıldı.
FULL TEXT (PDF): 
PDF icon arastirmax-erken-dogumun-onlenmesinde-nifedipin-ritodrinin-karsilastirilmasi.pdf
  • 2
87-90
  • Turkish

REFERENCES

References: 

1. Kupferminc M, Lessing JB, Yaron,
Peysen MR. Nifedipine versus ritodrine for suppression of preterm
labour. Br J Obstet Gynecol 1993;
100: 1090-1094.
2. Goldenberg RL, Rouse DJ.
Prevention of premature birth. N
Engl J Med 1998; 339: 313-320.
3. Lamont RF, Khan KS, Beattie B, et al;
Steering Group of the International
Preterm Labour Council. The quality
of nifedipine studies used to assess
tocolytic efficacy: a systematic review.
J Perinat Med 2005; 33: 287-295
4. Vermillion ST, Robinson CJ.
Antiprostaglandin drugs. Obstet
Gynecol Clin North Am 2005; 32:
501-517.
5. Crowther CA., Hiller JE, Doyle LW.
Magnesium sulphate for preventing
preterm birth in threatened preterm
labour. Cochrane Database Syst Rev
2002; (4): CD 001060.
6. Read MD, Wellby DE. The use of a
calcium antagonist (nifedipine) to
suppress preterm labour. Br J Obstet
Gynaecol 1986; 93: 933-937.
7. Pierzynski P, Lemancewicz A,
Reinheimer T, Akerlund M,
Laudanski T. Inhibitory effect of
barusiban and atosiban on oxytocininduced contractions of myometrium
from preterm and term pregnant
women. J Soc Gynecol Investig 2004;
11: 384-387.
8. Rowlands S, Trudinger B, VisvaLingam S. Treatment of preterm cervical dilatation with glyceryl trinitrate, a nitric oxide donor. Aust N Z J
Obstet Gynaecol 1996; 36: 377-381.
9. Ferguson, JEII, Dyson DC, Schutz T,
Stevenson DK. A comparison of
tocolysis with nifedipine or ritodrine:
Analysis of efficacy and maternal,
fetal and neonatal outcome. Am J
Obstet Gynecol 1990; 163: 605-611.
10. Gyetvai K, Hannah ME, Hodnett
ED, Ohlsson A. Tocolytics for
preterm labor: a systematic review.
Obstet Gynecol 1999; 94: 869-877.
11. Friedman DM, Blackstone J, Young
BK, Hoskins IA. Fetal cardiac effects
of oral ritodrine tocolysis. Am J
Perinatol 1994; 11: 109-112.
12. Groome LJ, Goldenberg RL, Cliver
SP, Davis RO, Copper RL. Neonatal
periventricular-intraventricular hemorrhage after maternal beta-sympathomimetic tocolysis. The March of
Dimes Multicenter Study Group. Am
J Obstet Gynecol 1992; 167: 873-879.
13. The Canadian Preterm Labor
Investigators Group. Treatment of
preterm labor with the beta adrenergic agonist ritodrine. N Engl J Med
1992; 327: 308-311.
14. Dodd JM, Crowther CA, Dare MR,
Middleton P. Oral betamimetics for
maintenance therapy after threatened
preterm labour. Cochrane Database
Syst Rev 2006; 25 (1): CD003927.
15. Ulmsten U, Anderson KR, Wingerup
L. Treatment of premature labor with
the calcium antagonist nifedipine.
Arch Gynecol 1980; 229: 1-5.
16. Fenakel K, Lurie S. The use of calcium channel blockers in obstetrics and
gynecology: a review. Eur J Obstet
Gynecol Reprod Biol 1990; 37: 199-
203.
17. Ulmsten U, Anderson KE, Forman
A. Relaxing effects of nifedipine on
the nonpregnant human uterus in
vitro and in vivo. Obstet Gynecol
1978; 52: 436-441.
18. Meyer WR, Rendall HW, Graves WL.
Nifedipine versus ritodrine for suppressing preterm labor. J Reprod Med
1990, 35: 649-653.
19. Cararach V, Palacio M, Martinez S, et
al. Nifedipine versus ritodrine for
suppression of preterm labor.
Comparison of their efficacy and secondary effects. Eur J Obstet Gynecol
Reprod Biol 2006; 127: 204-208.
20. Tsatsaris V, Papatsonis D, Goffinet F,
Dekker G, Carbonne B. Tocolysis
with nifedipine or beta-adrenergic
agonists: a meta-analysis. Obstet
Gynecol 2001; 97: 840-847.
21. Papatsonis DN, Van Geijn HP, Ader
HJ, Lange FM, Bleker OP, Dekker
GA. Nifedipine and ritodrine in the
management of preterm labor: a randomized multicenter trial. Obstet
Gynecol 1997; 90: 230-234.

Thank you for copying data from http://www.arastirmax.com